# Relmada Therapeutics, Inc.: Form 8-K, filed Apr 19, 2023

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: 8-K
- Filed: 2023-04-19
- Accepted by EDGAR: Apr 19, 2023, 09:25 ET
- Period: 2023-04-19
- Accession: 0001213900-23-030851
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000121390023030851/ea177149-8k_relmada.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000121390023030851/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000121390023030851/ea177149-8k_relmada.htm

Filed Apr 19, 2023.
Source: SEC EDGAR, the filing index for accession 0001213900-23-030851. Last ingested by Listed: Nov 13, 2026, 15:42 ET. No prices; not investment advice.
